Takatsuki, Japan

Akihisa Yoshimi


Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Osaka, JP (1996 - 2001)
  • Kyoto, JP (2008)
  • Takatsuki, JP (2000 - 2009)

Company Filing History:


Years Active: 1996-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Akihisa Yoshimi: Innovator in Medicinal Chemistry

Introduction

Akihisa Yoshimi is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of medicinal chemistry, holding a total of 8 patents. His work focuses on developing novel compounds with therapeutic applications, particularly in the treatment of diabetes and related conditions.

Latest Patents

Among his latest patents, Yoshimi has developed a heterocyclic compound that serves as a hypoglycemic agent and a therapeutic agent for diabetes and its complications. This compound is characterized by a specific formula that includes various functional groups, making it versatile in its medicinal applications. Another notable patent involves an indoline compound that exhibits superior ACAT inhibitory effects, positioning it as a potential treatment for conditions related to lipid metabolism.

Career Highlights

Yoshimi has worked with notable companies in the pharmaceutical industry, including Kyoto Pharmaceutical Industries, Ltd. and The Green Cross Corporation. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Yoshimi has collaborated with esteemed colleagues such as Hiroaki Shirahase and Masayasu Kasai. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Akihisa Yoshimi's contributions to medicinal chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to impact the development of therapeutic agents for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…